Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha.
dc.contributor.author | Babu, Sethu | en_US |
dc.date.accessioned | 2003-05-22 | en_US |
dc.date.accessioned | 2009-06-03T05:04:00Z | |
dc.date.available | 2003-05-22 | en_US |
dc.date.available | 2009-06-03T05:04:00Z | |
dc.date.issued | 2003-05-22 | en_US |
dc.identifier.citation | Babu S. Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha. National Medical Journal of India. 2003 May-Jun; 16(3): 175; author reply 175-6 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/118120 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.nmji.in | en_US |
dc.subject.mesh | Antiviral Agents --economics | en_US |
dc.subject.mesh | Cost-Benefit Analysis | en_US |
dc.subject.mesh | Developing Countries | en_US |
dc.subject.mesh | Disease Progression | en_US |
dc.subject.mesh | Drug Costs | en_US |
dc.subject.mesh | Hepatitis B, Chronic --drug therapy | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | India | en_US |
dc.subject.mesh | Interferon-alpha --economics | en_US |
dc.subject.mesh | Quality of Life | en_US |
dc.subject.mesh | Treatment Outcome | en_US |
dc.title | Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha. | en_US |
dc.type | Comment | en_US |
dc.type | Letter | en_US |
Files
License bundle
1 - 1 of 1